Brief: Dr. Ben Carson, Sr. Joins Galectin Therapeutics as Special Consultant
19/04/2021 14:37
April 19 (Reuters) - Galectin Therapeutics Inc GALT.O :
* GALECTIN THERAPEUTICS INC - ENGAGED BEN CARSON, SR., AS A
SPECIAL CONSULTANT TO ASSIST WITH DEVELOPMENT OF CO'S GALECTIN-3
INHIBITOR, BELAPECTIN
Source text for Eikon: ID:nGNXc4zFgY
Further company coverage: GALT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galectin Therapeutics
See all newsGalectin Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Galectin Therapeutics Reports June 30, 2026 Financial Results
Galectin Therapeutics Q2 loss widens
Galectin Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Galectin Therapeutics rises as FDA clears path for late-stage liver drug study